Wolfgang Oster to chair Formula
This article was originally published in Scrip
Privately-held oncology drug development company Formula Pharmaceuticals has appointed Dr Wolfgang Oster chair of the board. Dr Oster is managing partner for life science at Polytechnos Venture-Partners and an active entrepreneur. He is also a board member of Cappella, Intelligent Medical Implants, ImmunoGenes, Hemacon, Oncoceutics, Provid, Noblegen and Genossis.